FMC Plunges to $569M Loss on India Divestiture, Revenue Halves

Ticker: FMC · Form: 10-Q · Filed: Oct 30, 2025 · CIK: 37785

Sentiment: bearish

Topics: Agricultural Chemicals, Earnings Miss, Divestiture, Net Loss, Cash Flow Negative, Restructuring Charges, India Market

Related Tickers: FMC

TL;DR

**FMC's Q3 is a disaster, with a massive loss driven by a fire sale in India; steer clear until they show a clear path to profitability.**

AI Summary

FMC Corporation reported a significant decline in financial performance for the three and nine months ended September 30, 2025. Revenue for the three months decreased by 49.1% to $542.2 million from $1,065.4 million in the prior year, while net loss attributable to FMC stockholders widened to $569.3 million from a net income of $65.0 million. For the nine months, revenue fell by 21.1% to $2,384.1 million from $3,021.8 million, and the company posted a net loss of $518.1 million compared to a net income of $357.4 million in 2024. A major factor contributing to the loss was a $510 million charge related to the planned divestiture of its India commercial business, including a $282.2 million non-cash commercial action for the India business held for sale. Restructuring and other charges also surged to $294.5 million for the quarter and $349.0 million for the nine months, up from $22.6 million and $158.6 million respectively in 2024. The company's cash provided by operating activities of continuing operations turned negative, with a requirement of $663.3 million for the nine months ended September 30, 2025, compared to a provision of $308.8 million in the prior year.

Why It Matters

FMC's substantial net loss and revenue decline, largely driven by the India business divestiture, signal significant operational challenges and strategic shifts. For investors, this indicates potential volatility and a need to re-evaluate FMC's growth prospects and risk profile, especially given the $510 million charge. Employees in the India commercial business face uncertainty due to the planned sale. Customers might experience changes in product availability or service as FMC streamlines its global operations. Competitively, this move could allow rivals to gain market share in India, while FMC focuses on more profitable regions, potentially impacting its global standing in the agricultural chemicals sector.

Risk Assessment

Risk Level: high — The risk level is high due to a net loss of $569.3 million for the quarter and $518.1 million for the nine months ended September 30, 2025, a stark reversal from prior year profits. This includes a significant $510 million charge related to the India business divestiture, indicating substantial asset impairment and operational issues. Furthermore, cash provided by operating activities of continuing operations turned negative, requiring $663.3 million for the nine months, compared to providing $308.8 million in the prior year, signaling severe cash flow strain.

Analyst Insight

Investors should exercise extreme caution and consider reducing exposure to FMC. The significant net loss, negative operating cash flow, and large one-time charges related to the India divestiture indicate deep-seated operational and strategic issues. Wait for clear evidence of stabilization and a return to profitability before considering any new investment.

Financial Highlights

revenue
$542.2M
net Income
$(569.3)M
eps
$(4.52)
gross Margin
23.8%
revenue Growth
-49.1%

Revenue Breakdown

SegmentRevenueGrowth
North America$751.7M-9.8%
Latin America$980.3M-1.9%
Europe, Middle East & Africa (EMEA)$687.7M+6.3%
Asia-$35.6M-106.6%

Key Numbers

Key Players & Entities

FAQ

What caused FMC Corporation's significant net loss in Q3 2025?

FMC Corporation's significant net loss of $569.3 million in Q3 2025 was primarily caused by a $510 million charge related to the planned divestiture of its India commercial business. This included $282.2 million in non-cash commercial actions and an asset impairment charge.

How did FMC's revenue perform in the third quarter of 2025?

FMC's revenue for the three months ended September 30, 2025, decreased by 49.1% to $542.2 million, down from $1,065.4 million in the same period of 2024.

What is the strategic reason behind FMC's divestiture of its India business?

FMC's Board of Directors approved the plan to divest the India commercial business in July 2025 in response to ongoing commercial challenges in the country, aiming to optimize its portfolio.

What was the impact of the India divestiture on FMC's balance sheet?

The assets associated with the India commercial business, which had a carrying value of approximately $960 million at June 30, 2025, were written down to an estimated fair value less costs to sell of $450 million, resulting in a $510 million charge.

How did FMC's cash flow from operations change in the first nine months of 2025?

Cash provided by operating activities of continuing operations for FMC turned negative, requiring $663.3 million for the nine months ended September 30, 2025, compared to providing $308.8 million in the same period of 2024.

What are the implications of the increased restructuring charges for FMC?

Restructuring and other charges significantly increased to $349.0 million for the nine months ended September 30, 2025, from $158.6 million in the prior year, indicating ongoing efforts to streamline operations and potentially reduce costs, but also reflecting significant one-time expenses.

How does FMC's current financial performance compare to the previous year?

FMC's financial performance in 2025 has significantly deteriorated compared to 2024, moving from a net income of $357.7 million for the nine months ended September 30, 2024, to a net loss of $516.4 million for the same period in 2025.

What is the outlook for FMC's India business after the divestiture plan?

The sale process for FMC's India commercial business is underway and is expected to conclude within the next twelve months. Until then, the business will continue to be presented in the Company's reported GAAP results.

What is FMC's current debt situation?

FMC's short-term debt and current portion of long-term debt increased significantly to $1,271.7 million at September 30, 2025, from $337.4 million at December 31, 2024, while long-term debt also increased to $3,270.5 million.

What should investors consider regarding FMC's stock given this 10-Q filing?

Investors should note the substantial net loss, negative operating cash flow, and significant one-time charges. These factors suggest increased financial risk and operational challenges, warranting careful consideration and potentially a bearish outlook until a clear recovery strategy is demonstrated.

Risk Factors

Industry Context

The agricultural sciences industry is characterized by intense competition, significant R&D investment, and increasing regulatory scrutiny. Companies like FMC focus on developing innovative crop protection solutions, including insecticides, herbicides, and fungicides, to address evolving pest resistance and environmental concerns. Trends include a growing demand for sustainable and biological products, alongside consolidation within the sector.

Regulatory Implications

FMC faces ongoing regulatory challenges related to product registration, environmental impact, and international trade policies. The company's recent accounting standard updates (ASU 2024-03 and ASU 2023-09) indicate a dynamic regulatory environment for financial reporting, requiring adaptation in disclosures.

What Investors Should Do

  1. Monitor India Divestiture Progress
  2. Analyze Operating Cash Flow Trends
  3. Assess Debt Structure and Leverage
  4. Evaluate Restructuring Impact

Key Dates

Glossary

Held for sale
Assets designated for sale within one year, with their carrying amount adjusted to fair value less costs to sell. (Applies to FMC's India commercial business, leading to a $510 million charge and reclassification of assets on the balance sheet.)
Restructuring and other charges
Costs incurred due to significant reorganizations, business exits, or other major business changes. (These charges surged to $294.5 million in Q3 2025 and $349.0 million for the nine months, significantly impacting net income.)
Continuing operations
The ongoing business activities of a company, excluding those that have been divested or are planned for divestiture. (Used to analyze the core performance of FMC, highlighting a negative cash flow of $663.3 million for the nine months.)
Non-cash commercial actions
Adjustments to revenue or expenses that do not involve an immediate outflow or inflow of cash, such as product returns or pricing changes. (A $282.2 million non-cash charge was recorded for the India business held for sale, impacting reported earnings without affecting immediate cash.)
Discontinued operations
A segment of a business that has been disposed of or is classified as held for sale, and whose operations and cash flows will be eliminated from the ongoing entity. (FMC's India business did not qualify for discontinued operations treatment, meaning its results are included in continuing operations until sale.)

Year-Over-Year Comparison

FMC Corporation's Q3 2025 results show a dramatic downturn compared to Q3 2024. Revenue plummeted by 49.1% to $542.2 million, and the company swung from a net income of $65.0 million to a net loss of $569.3 million. This performance is heavily impacted by a $510 million charge for the India divestiture and a significant increase in restructuring costs. Operating cash flow has also reversed from positive to a substantial negative requirement, signaling a weakening financial position.

Filing Stats: 4,960 words · 20 min read · ~17 pages · Grade level 6.3 · Accepted 2025-10-30 14:07:21

Key Financial Figures

Filing Documents

- FINANCIAL INFORMATION

Part I - FINANCIAL INFORMATION 3

Financial Statements

Item 1. Financial Statements 3 Consolidated Statements of Income (Loss) - Three and nine months ended September 30, 2025 and 2024 (unaudited) 3 Consolidated Statements of Comprehensive Income (Loss) - Three and nine months ended September 30, 2025 and 2024 (unaudited) 4 Consolidated Balance Sheets - September 30, 2025 (unaudited) and December 31, 2024 5 Consolidated Statements of Cash Flows - Nine months ended September 30, 2025 and 2024 (unaudited) 6 Consolidated Statements of Changes in Equity - Three and nine months ended September 30, 2025 and 2024 (unaudited) 8

Notes to Consolidated Financial Statements (unaudited)

Notes to Consolidated Financial Statements (unaudited) 10

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 37

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 60

Controls and Procedures

Item 4. Controls and Procedures 60

- OTHER INFORMATION

Part II - OTHER INFORMATION 61

Legal Proceedings

Item 1. Legal Proceedings 61

Risk Factors

Item 1A. Risk Factors 61

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 61

Other Information

Item 5. Other Information 61

Exhibits

Item 6. Exhibits 62

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS FMC CORPORATION CONSOLIDATED STATEMENTS OF INCOME (LOSS) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 (in Millions, Except Per Share Data) (unaudited) (unaudited) Revenue $ 542.2 $ 1,065.4 $ 2,384.1 $ 3,021.8 Costs and Expenses Costs of sales and services 413.3 679.0 1,532.2 1,897.6 Gross margin $ 128.9 $ 386.4 $ 851.9 $ 1,124.2 Selling, general and administrative expenses 167.4 159.2 516.2 487.9 Research and development expenses 63.3 69.0 198.4 205.8 Restructuring and other charges (income) 294.5 22.6 349.0 158.6 Total costs and expenses $ 938.5 $ 929.8 $ 2,595.8 $ 2,749.9 Income from continuing operations before non-operating pension, postretirement and other charges (income), interest expense, net and income taxes $ ( 396.3 ) $ 135.6 $ ( 211.7 ) $ 271.9 Non-operating pension, postretirement and other charges (income) 5.6 4.4 15.4 12.9 Interest expense, net 64.1 58.7 175.2 184.0 Income (loss) from continuing operations before income taxes $ ( 466.0 ) $ 72.5 $ ( 402.3 ) $ 75.0 Provision (benefit) for income taxes 82.2 6.0 110.1 ( 298.9 ) Income (loss) from continuing operations $ ( 548.2 ) $ 66.5 $ ( 512.4 ) $ 373.9 Discontinued operations, net of income taxes ( 20.4 ) ( 0.9 ) ( 4.0 ) ( 16.2 ) Net income (loss) $ ( 568.6 ) $ 65.6 $ ( 516.4 ) $ 357.7 Less: Net income (loss) attributable to noncontrolling interests 0.7 0.6 1.7 0.3 Net income (loss) attributable to FMC stockholders $ ( 569.3 ) $ 65.0 $ ( 518.1 ) $ 357.4 Amounts attributable to FMC stockholders: Continuing operations, net of income taxes $ ( 548.9 ) $ 65.9 $ ( 514.1 ) $ 373.6 Discontinued operations, net of income taxes ( 20.4 ) ( 0.9 ) ( 4.0 ) ( 16.2 ) Net income (loss) attributable to FMC stockholders $ ( 569.3 ) $ 65.0 $ ( 518.1 ) $ 357.4 Basic earnings (loss) per common share attributable to FMC stockholders: Continuing operations $ ( 4.36 ) $ 0.53 $ ( 4.08 ) $ 2.98 Discontinued operations ( 0.1

Notes to Consolidated Financial Statements (unaudited)

Notes to Consolidated Financial Statements (unaudited) Note 1: Financial Information and Accounting Policies In our opinion, the consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") applicable to interim period financial statements and reflect all adjustments necessary for a fair statement of results of operations for the three and nine months ended September 30, 2025 and 2024, cash flows for the nine months ended September 30, 2025 and 2024, changes in equity for the three and nine months ended September 30, 2025 and 2024, and our financial positions as of September 30, 2025 and December 31, 2024. All such adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the Notes. The results of operations for the three and nine months ended September 30, 2025 and 2024 are not necessarily indicative of the results of operations for the full year. The consolidated balance sheet as of December 31, 2024 was audited by our independent registered public accountants. Our accounting policies are set forth in detail in Note 1 to the consolidated financial statements included with our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") for the year ended December 31, 2024 (the "2024 Form 10-K"). India Held for Sale Business In July 2025, the Board of Directors approved a plan to divest the Company's commercial business in India in response to ongoing commercial challenges in the country. The sale process is underway and is expected to conclude within the next twelve months; and, therefore, the assets related to this business are classified as held for sale beginning in the third quarter of 2025. The business does not qualify for recognition as discontinued operations and will continue to be presented in the Company's reported GAAP results until a transaction is completed. Total adjustment - approximately $ 510 million The asse

Notes to Consolidated Financial Statements (unaudited) — (Continued)

Notes to Consolidated Financial Statements (unaudited) — (Continued) The table below summarizes the assets and liabilities classified as held for sale in the consolidated balance sheet: (in millions) September 30, 2025 Trade receivables, net of allowance of $ 3.6 million $ 563.6 Inventories 136.9 Prepaid and other current assets (1) 178.4 Property, plant and equipment, net 9.2 Goodwill 163.1 Other assets 2.1 Impairment on assets held for sale ( 226.8 ) Assets held for sale $ 826.5 Accounts payable, trade and other $ 5.1 Accrued and other liabilities 294.7 Accrued customer rebates 76.7 Liabilities held for sale $ 376.5 Net assets held for sale $ 450.0 ___________________________________ (1) Primarily consists of the refund asset for the expected recovery of products from customers, which is recorded in connection with our estimated sales return liability. GSS Divestiture On November 1, 2024, we completed the sale of our Global Specialty Solutions ("GSS") business to Environmental Science US, LLC d/b/a Envu ("Envu") and received proceeds, net of the preliminary working capital adjustment, of approximately $ 340 million. During the second and third quarters of 2025, certain foreign assets, consisting primarily of working capital balances, were transferred to Envu as a result of local timing constraints at the time of the sale. We received consideration for the foreign assets, which were not material, at closing of the sale in 2024 and no additional consideration was received at the date of transfer. Note 2: Recently Issued and Adopted Accounting Pronouncements and Regulatory Items New accounting guidance and regulatory items On November 4, 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income (Topic 220): Expense Disaggregation Disclosures, to require disaggregation of certain expense captions into specified categories in disclosures within the notes of the financial statements. The standard is effective for

Notes to Consolidated Financial Statements (unaudited) — (Continued)

Notes to Consolidated Financial Statements (unaudited) — (Continued) Note 3: Revenue Recognition Disaggregation of revenue We disaggregate revenue from contracts with customers by geographical areas and major product categories. We have three major agricultural product categories: insecticides, herbicides, and fungicides. Plant health, which includes biological products, is also included in the below table. The following table provides information about disaggregated revenue by major geographical region: Three Months Ended September 30, Nine Months Ended September 30, (in Millions) 2025 2024 2025 2024 North America $ 244.4 $ 235.5 $ 751.7 $ 833.4 Latin America 463.1 504.1 980.3 999.3 Europe, Middle East & Africa (EMEA) 154.5 139.3 687.7 647.3 Asia (1) ( 319.8 ) 186.5 ( 35.6 ) 541.8 Total Revenue $ 542.2 $ 1,065.4 $ 2,384.1 $ 3,021.8 ___________________________________ (1) During the t

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing